783 results on '"Richmond, Ann"'
Search Results
152. Proteolytic Cleavage and Activation of pro-Macrophage-Stimulating Protein and Upregulation of its Receptor in Tissue Injury
153. Growth and Differentiation in Melanocytes
154. A Novel NF-κB-inducing Kinase-MAPK Signaling Pathway Up-regulates NF-κB Activity in Melanoma Cells
155. Hsc/Hsp70 Interacting Protein (Hip) Associates with CXCR2 and Regulates the Receptor Signaling and Trafficking
156. Purification and characterization of recombinant melanoma growth stimulating activity
157. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade.
158. At the Bench: Pre‐clinical evidence for multiple functions of CXCR4 in cancer.
159. Protein Phosphatase 2A Interacts with and Directly Dephosphorylates RelA
160. The Role of CDP in the Negative Regulation ofCXCL1 Gene Expression
161. DEVELOPMENTAL EXPRESSION OF TWO CXC CHEMOKINES, MIP-2 AND KC, AND THEIR RECEPTORS
162. Phosphorylation-independent Association of CXCR2 with the Protein Phosphatase 2A Core Enzyme
163. A Role for Poly(ADP-ribose) Polymerase in the Transcriptional Regulation of the Melanoma Growth Stimulatory Activity (CXCL1) Gene Expression
164. Nuclear Factor-κB Activation by the CXC Chemokine Melanoma Growth-stimulatory Activity/Growth-regulated Protein Involves the MEKK1/p38 Mitogen-activated Protein Kinase Pathway
165. Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms
166. Abstract 4948: MDM2 antagonism overcomes resistance to CDK4/6 inhibition in melanoma
167. Abstract 5466: CXCL14 suppresses the aggressive phenotype in triple-negative breast cancer (TNBC) through CXCR4
168. Abstract 607: Inhibition of CDK4/6 and Pi3Kγ modulates mammary tumor immune microenvironment to enhance response to immunotherapy
169. Engineered microfluidic bioreactor for examining the three-dimensional breast tumor microenvironment
170. Chapter Two - Study of Chemotaxis and Cell–Cell Interactions in Cancer with Microfluidic Devices
171. Role of Clathrin-mediated Endocytosis in CXCR2 Sequestration, Resensitization, and Signal Transduction
172. Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma
173. Abstract B166: Investigating the effect of CDK4/6 and MDM2 inhibition on melanoma
174. MDM2 Antagonists Counteract Drug-Induced DNA Damage
175. Abstract 513: The link between polyploidy and replication stress in melanoma
176. Abstract 3928: Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients
177. PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses
178. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo
179. Micrometastatic Dormancy in Uveal Melanoma: A Comprehensive Review of the Evidence, Mechanisms, and Implications for Future Adjuvant Therapies
180. Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function
181. Abstract 1410: PI3K inhibitors reduce breast cancer tumor growth and enhance anti-tumor leukocyte activity
182. Abstract 4268: Examining the 3D tumor microenvironment via microbioreactors
183. Abstract 5126: The link between therapy-induced senescence and anti-tumor immune microenvironment in melanoma
184. Combinatorial approach to cancer immunotherapy: strength in numbers
185. Using avatars to win the fight over BRAF inhibitor resistance
186. Disparities in Uveal Melanoma: Patient Characteristics
187. Tumor Characteristics, Genetics, Management, and the Risk of Metastasis in Uveal Melanoma
188. Epithelial NF-κB signaling promotes EGFR-driven lung carcinogenesis via macrophage recruitment
189. Th9 and Th17 cells: the controversial twins in cancer immunity.
190. Multimodal Multiplexed Immunoimaging with Nanostars to Detect Multiple Immunomarkers and Monitor Response to Immunotherapies
191. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
192. Development of novel murine mammary imaging windows to examine wound healing effects on leukocyte trafficking in mammary tumors with intravital imaging
193. Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment
194. Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models
195. Chemokine Regulation of Neutrophil Infiltration of Skin Wounds
196. The role of NF-kB in modulating antitumor immunity
197. Abstract 422: The role of CCL2 in the breast cancer tumor microenvironment and metastasis
198. Abstract B11: Manipulating senescence to combat melanoma initiation and progression
199. Abstract B12: Synergistic anticancer activity of Aurora A kinase and MDM2 antagonists in melanoma
200. Combined therapies that induce senescence and stabilize p53 block melanoma growth and prompt antitumor immune responses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.